SCHEMBL8780227

SCHEMBL8780227

CC(C)c1cc(Sc2ccc(F)cc2)cc(-c2ccc(F)cc2)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.50
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
BCL2 P10415 2/20 0.38
MCL1 Q07820 2/20 0.38
PTPN1 P18031 1/20 0.37
CDC25A P30304 1/20 0.37
CDC25B P30305 1/20 0.37
GCGR P47871 4/20 0.35
RPS6KA3 P51812 1/20 0.35
GSK3B P49841 1/20 0.34
MAPK14 Q16539 2/20 0.33
DHODH Q02127 1/20 0.33
PTGS1 P23219 1/20 0.33
AGBL2 Q5U5Z8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9194475 0.93 HMGCR (0.45) HMGCRMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL9199852 0.88 HMGCR (0.42) HMGCRMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL9197287 0.85 HMGCR (0.38) HMGCRMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL8780157 0.82 PTGS2 (0.37) HMGCRCA1CA2GCGRRPS6KA3
SCHEMBL9512239 0.80 CA1 (0.53) HMGCRCYP1A2CA1CA2GCGR
SCHEMBL8780176 0.78 GABRA1 (0.50) HMGCRCA1CA2GCGRRPS6KA3
SCHEMBL9199239 0.77 CA1 (0.41) HMGCRCYP1A2CA1CA2GCGR
SCHEMBL9514348 0.75 CA1 (0.47) HMGCRMEN1KMT2ACA1CA2
SCHEMBL9516053 0.75 CA1 (0.39) CA1CA2
SCHEMBL9701896 0.73 CA1 (0.61) MEN1CYP1A2CYP2C9CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5668126-A ORAL ADMINISTRATION OF HMG-COA REDUCTASE INHIBITOR HOECHST AKTIENGESELLSCHAFT (DE) 1997-09-16 US disclosed
US-5646272-A WITH IMPROVED ABSORPTION INTO THE BLOODSTREAM HOECHST AKTIENGESELLSCHAFT (DE) 1997-07-08 US disclosed
EP-0417725-B1 Bile-acid derivatives, a process for their production and their use as medicines HOECHST AG (DE) 1997-04-23 EP disclosed
US-5462933-A Oral administering HOECHST AKTIENGESELLSCHAFT (DE) 1995-10-31 US disclosed
EP-0418648-B1 4-Hydroxytetrahydropyran-2-ones as well as the corresponding dehydroxy carbon acid derivatives, salts and esters, process for their preparation, pharmaceutical preparations as well as precursors HOECHST AG (DE) 1995-01-11 EP disclosed
US-5294724-A Anticholesterol agents HOECHST AKTIENGESELLSCHAFT (DE) 1994-03-15 US disclosed
EP-0418648-A1 4-Hydroxytetrahydropyran-2-ones as well as the corresponding dehydroxy carbon acid derivatives, salts and esters, process for their preparation, pharmaceutical preparations as well as precursors HOECHST AKTIENGESELLSCHAFT (DE) 1991-03-27 EP disclosed
EP-0417725-A2 Bile-acid derivatives, a process for their production and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1991-03-20 EP disclosed